Johnson Financial Group Inc (Wisconsin)’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-151	Closed	-$2.67K	–	950
2024 Q4	$2.67K	Buy	151 +131	+655%	+$2.38K	﹤0.01%	788
2024 Q3	$361	Hold	20	–	–	﹤0.01%	899
2024 Q2	$325	Hold	20	–	–	﹤0.01%	812
2024 Q1	$283	Hold	20	–	–	﹤0.01%	743
2023 Q4	$209	Buy	+20	New	+$187	﹤0.01%	876
2014 Q2	–	Sell	-130	Closed	-$7K	–	722
2014 Q1	$7K	Buy	+130	New	+$6.01K	﹤0.01%	614
2013 Q4	–	Sell	-300	Closed	-$11K	–	729
2013 Q3	$11K	Sell	300 -1,510	-83%	-$58.9K	﹤0.01%	553
2013 Q2	$71K	Buy	+1,810	New	+$70.5K	0.02%	375

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s TEVA Position: Q1 2025 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2025, closing a stake of 151 shares — an estimated $2.67K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $71K in Q2 2013. 563 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

Johnson Financial Group Inc (Wisconsin) reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2025 after selling out during the quarter.
Johnson Financial Group Inc (Wisconsin) sold 151 Teva Pharmaceutical Industries Limited shares in Q1 2025, an estimated $2.67K.
Johnson Financial Group Inc (Wisconsin) first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 8 quarters.
Johnson Financial Group Inc (Wisconsin)'s Teva Pharmaceutical Industries Limited position peaked at $71K in Q2 2013.
563 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2025.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2025, filed 15 May 2025.